BioLife Solutions launches its new biopreservation platform, which improves upon methods for the cryopreservation of adult stem cells derived from umbilical cord blood and peripheral blood.
The biotech company BrainStorm Cell Therapeutics enters into an agreement for the production of clinical-grade adult stem cells as a treatment of ALS.
Recent studies indicate that a lack of public education about cord-blood-derived adult stem cells is hindering therapeutic progress.
Vet-Stem, the highly successful U.S. veterinary adult stem cell company, now offers a service which allows for an "everlasting" supply of adult stem cells.
Scientists in Germany have simplified the iPS (induced pluripotent stem) cell reprogramming procedure from four genes to one gene, though the choice of cell type plays an important role.
At last, for the first time, Geron offers an explanation for the FDA-imposed hold on its highly publicized human embryonic stem cell clinical trial.
Toll Free:
1-800-980-STEM (7836)
Outside or Inside US Call:
1-954-358-3382
Toll Free Fax (US Only):
1-866-755-3951
From Outside US Fax:
1-775-887-1194
Copyright 2025, Stem Cell Insitute Panama. All rights reserved.
